View in EDS HTML Full Text PDF Full Text

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Saved in:
Bibliographic Details
Title: Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Authors: Mileva M; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., de Vries EGE; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Guiot T; Department of Medical Physics, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Wimana Z; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Department of Radiopharmacy, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Deleu AL; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Schröder CP; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands., Lefebvre Y; Department of Radiology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Paesmans M; Data Center, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Stroobants S; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium., Huizing M; Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium., Aftimos P; Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Tol J; Department of Internal Medicine, Jeroen Bosch Ziekenhuis, Den Bosch, The Netherlands., Van der Graaf WTA; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands., Oyen WJG; Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands., Vugts DJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands., Menke-van der Houven van Oordt CW; Department of Medical Oncology, Amsterdam UMC Location VUMC, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Brouwers AH; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands., Piccart-Gebhart M; Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Flamen P; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium., Gebhart G; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. geraldine.gebhart@hubruxelles.be.
Source: NPJ breast cancer [NPJ Breast Cancer] 2024 Jan 06; Vol. 10 (1), pp. 4. Date of Electronic Publication: 2024 Jan 06.
Publication Type: Journal Article
Journal Info: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38184611
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Mileva+M%22">Mileva M</searchLink>; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22de+Vries+EGE%22">de Vries EGE</searchLink>; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Guiot+T%22">Guiot T</searchLink>; Department of Medical Physics, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Wimana+Z%22">Wimana Z</searchLink>; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.; Department of Radiopharmacy, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Deleu+AL%22">Deleu AL</searchLink>; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Schröder+CP%22">Schröder CP</searchLink>; Department of Medical Oncology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Lefebvre+Y%22">Lefebvre Y</searchLink>; Department of Radiology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Paesmans+M%22">Paesmans M</searchLink>; Data Center, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Stroobants+S%22">Stroobants S</searchLink>; Department of Nuclear Medicine, Antwerp University Hospital, Edegem, Belgium.<br /><searchLink fieldCode="AU" term="%22Huizing+M%22">Huizing M</searchLink>; Department of Medical Oncology, Antwerp University Hospital, Edegem, Belgium.<br /><searchLink fieldCode="AU" term="%22Aftimos+P%22">Aftimos P</searchLink>; Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Tol+J%22">Tol J</searchLink>; Department of Internal Medicine, Jeroen Bosch Ziekenhuis, Den Bosch, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Van+der+Graaf+WTA%22">Van der Graaf WTA</searchLink>; Department of Medical Oncology, Antoni van Leeuwenhoek-Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Oyen+WJG%22">Oyen WJG</searchLink>; Humanitas Clinical and Research Center, Humanitas University, Milan, Italy.; Department of Radiology and Nuclear Medicine, Rijnstate Hospital, Arnhem, The Netherlands.; Department of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vugts+DJ%22">Vugts DJ</searchLink>; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit, Cancer Center Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Menke-van+der+Houven+van+Oordt+CW%22">Menke-van der Houven van Oordt CW</searchLink>; Department of Medical Oncology, Amsterdam UMC Location VUMC, Cancer Centre Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Brouwers+AH%22">Brouwers AH</searchLink>; Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Piccart-Gebhart+M%22">Piccart-Gebhart M</searchLink>; Department of Medical Oncology, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Flamen+P%22">Flamen P</searchLink>; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Gebhart+G%22">Gebhart G</searchLink>; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (H.U.B), Université Libre de Bruxelles (ULB), Brussels, Belgium. geraldine.gebhart@hubruxelles.be.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101674891%22">NPJ breast cancer</searchLink> [NPJ Breast Cancer] 2024 Jan 06; Vol. 10 (1), pp. 4. <i>Date of Electronic Publication: </i>2024 Jan 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Breast+Cancer+Research+Foundation%22">Breast Cancer Research Foundation </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101674891 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Print <i>ISSN: </i>2374-4677 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2223744677%22">23744677 </searchLink><i>NLM ISO Abbreviation: </i>NPJ Breast Cancer <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38184611
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41523-023-00610-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4
    Titles:
      – TitleFull: Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Mileva M
      – PersonEntity:
          Name:
            NameFull: de Vries EGE
      – PersonEntity:
          Name:
            NameFull: Guiot T
      – PersonEntity:
          Name:
            NameFull: Wimana Z
      – PersonEntity:
          Name:
            NameFull: Deleu AL
      – PersonEntity:
          Name:
            NameFull: Schröder CP
      – PersonEntity:
          Name:
            NameFull: Lefebvre Y
      – PersonEntity:
          Name:
            NameFull: Paesmans M
      – PersonEntity:
          Name:
            NameFull: Stroobants S
      – PersonEntity:
          Name:
            NameFull: Huizing M
      – PersonEntity:
          Name:
            NameFull: Aftimos P
      – PersonEntity:
          Name:
            NameFull: Tol J
      – PersonEntity:
          Name:
            NameFull: Van der Graaf WTA
      – PersonEntity:
          Name:
            NameFull: Oyen WJG
      – PersonEntity:
          Name:
            NameFull: Vugts DJ
      – PersonEntity:
          Name:
            NameFull: Menke-van der Houven van Oordt CW
      – PersonEntity:
          Name:
            NameFull: Brouwers AH
      – PersonEntity:
          Name:
            NameFull: Piccart-Gebhart M
      – PersonEntity:
          Name:
            NameFull: Flamen P
      – PersonEntity:
          Name:
            NameFull: Gebhart G
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 01
              Text: 2024 Jan 06
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 2374-4677
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: NPJ breast cancer
              Type: main
ResultId 1